<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Toxins (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Toxins (Basel)</journal-id><journal-id journal-id-type="publisher-id">toxins</journal-id><journal-title-group><journal-title>Toxins</journal-title></journal-title-group><issn pub-type="epub">2072-6651</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5705957</article-id><article-id pub-id-type="doi">10.3390/toxins9110342</article-id><article-id pub-id-type="publisher-id">toxins-09-00342</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Isolation and Functional Characterization of an Acidic Myotoxic Phospholipase A<sub>2</sub> from Colombian <italic>Bothrops asper</italic> Venom</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Posada Arias</surname><given-names>Silvia</given-names></name><xref ref-type="aff" rid="af1-toxins-09-00342">1</xref><xref ref-type="aff" rid="af2-toxins-09-00342">2</xref><xref rid="c1-toxins-09-00342" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Rey-Su&#225;rez</surname><given-names>Paola</given-names></name><xref ref-type="aff" rid="af1-toxins-09-00342">1</xref></contrib><contrib contrib-type="author"><name><surname>Pere&#225;&#241;ez J</surname><given-names>Andr&#233;s</given-names></name><xref ref-type="aff" rid="af1-toxins-09-00342">1</xref></contrib><contrib contrib-type="author"><name><surname>Acosta</surname><given-names>Cristian</given-names></name><xref ref-type="aff" rid="af1-toxins-09-00342">1</xref></contrib><contrib contrib-type="author"><name><surname>Rojas</surname><given-names>Mauricio</given-names></name><xref ref-type="aff" rid="af3-toxins-09-00342">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5832-1825</contrib-id><name><surname>Delazari dos Santos</surname><given-names>Lucilene</given-names></name><xref ref-type="aff" rid="af4-toxins-09-00342">4</xref></contrib><contrib contrib-type="author"><name><surname>Ferreira Jr</surname><given-names>Rui Seabra</given-names></name><xref ref-type="aff" rid="af4-toxins-09-00342">4</xref></contrib><contrib contrib-type="author"><name><surname>N&#250;&#241;ez</surname><given-names>Vitelbina</given-names></name><xref ref-type="aff" rid="af1-toxins-09-00342">1</xref><xref ref-type="aff" rid="af5-toxins-09-00342">5</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Brierley</surname><given-names>Stuart M.</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Vetter</surname><given-names>Irina</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-toxins-09-00342"><label>1</label>Programa de Ofidismo y Escorpionismo, Universidad de Antioquia, Medell&#237;n 050010, Colombia; <email>ofidpa@gmail.com</email> (P.R.-S.); <email>andrespj20@gmail.com</email> (A.P.J.); <email>cj.acosta1@hotmail.com</email> (C.A.); <email>vitelbina.nunez@gmail.com</email> (V.N.)</aff><aff id="af2-toxins-09-00342"><label>2</label>Research Group in Veterinary Medicine GIVET, School of Veterinary Medicine, Corporaci&#243;n Universitaria Lasallista, Caldas-Antioquia 055440, Colombia</aff><aff id="af3-toxins-09-00342"><label>3</label>Grupo de Inmunolog&#237;a Celular e Inmunogen&#233;tica (GICIG), Universidad de Antioquia, Medell&#237;n 050010, Colombia; <email>mauricio.rojas@udea.edu.co</email></aff><aff id="af4-toxins-09-00342"><label>4</label>Center for the Study of Venoms and Venomous Animals (CEVAP), Universidad Estadual Paulista (UNESP) and Graduate Program in Tropical Diseases, Botucatu Medical School (FMB), Botucatu, S&#227;o Paulo 18610-307, Brazil; <email>lucilenebio@gmail.com</email> (L.D.d.S.); <email>rui.ead@gmail.com</email> (R.S.F.J.)</aff><aff id="af5-toxins-09-00342"><label>5</label>Escuela de Microbiolog&#237;a, Universidad de Antioquia, Medell&#237;n 050010, Colombia</aff><author-notes><corresp id="c1-toxins-09-00342"><label>*</label>Correspondence: <email>silviaposada@gmail.com</email>; Tel.: +57-4219-6649</corresp></author-notes><pub-date pub-type="epub"><day>26</day><month>10</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>11</month><year>2017</year></pub-date><volume>9</volume><issue>11</issue><elocation-id>342</elocation-id><history><date date-type="received"><day>12</day><month>9</month><year>2017</year></date><date date-type="accepted"><day>11</day><month>10</month><year>2017</year></date></history><permissions><copyright-statement>&#169; 2017 by the authors.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Myotoxic phospholipases A<sub>2</sub> (PLA<sub>2</sub>) are responsible for many clinical manifestations in envenomation by <italic>Bothrops</italic> snakes. A new myotoxic acidic Asp49 PLA<sub>2</sub> (BaCol PLA<sub>2</sub>) was isolated from Colombian <italic>Bothrops asper</italic> venom using reverse-phase high performance liquid chromatography (RP-HPLC). BaCol PLA<sub>2</sub> had a molecular mass of 14,180.69 Da (by mass spectrometry) and an isoelectric point of 4.4. The complete amino acid sequence was obtained by cDNA cloning (GenBank accession No. MF319968) and revealed a mature product of 124 amino acids with Asp at position 49. BaCol PLA<sub>2</sub> showed structural homology with other acidic PLA<sub>2</sub> isolated from <italic>Bothrops</italic> venoms, including a non-myotoxic PLA<sub>2</sub> from Costa Rican <italic>B. asper</italic>. In vitro studies showed cell membrane damage without exposure of phosphatidylserine, an early apoptosis hallmark. BaCol PLA<sub>2</sub> had high indirect hemolytic activity and moderate anticoagulant action. In mice, BaCol PLA<sub>2</sub> caused marked edema and myotoxicity, the latter seen as an increase in plasma creatine kinase and histological damage to gastrocnemius muscle fibers that included vacuolization and hyalinization necrosis of the sarcoplasm.</p></abstract><kwd-group><kwd>acidic myotoxic phospholipase A<sub>2</sub></kwd><kwd><italic>Bothrops asper</italic></kwd><kwd>edema</kwd><kwd>myotoxicity</kwd><kwd>snake venom</kwd></kwd-group></article-meta></front><body><sec id="sec1-toxins-09-00342"><title>1. Introduction</title><p>Colombia has the third highest biodiversity of snakes in the Americas [<xref rid="B1-toxins-09-00342" ref-type="bibr">1</xref>]. In 2015, there were 4273 clinically confirmed cases of snakebite in the country, with an average of 82.2 snakebites per week and an incidence of 8.84 cases per 100,000 habitants [<xref rid="B2-toxins-09-00342" ref-type="bibr">2</xref>]. Approximately 94.6% of the snakebites are caused by snakes of the genus <italic>Bothrops</italic> [<xref rid="B2-toxins-09-00342" ref-type="bibr">2</xref>].</p><p>In Colombia, <italic>Bothrops asper</italic> is found in the Pacific, Caribbean and Andean (western slopes) regions where it accounts for 50&#8211;80% of snakebites [<xref rid="B2-toxins-09-00342" ref-type="bibr">2</xref>]. Envenomation by <italic>B. asper</italic> leads to sequelae in 6&#8211;10% of cases [<xref rid="B2-toxins-09-00342" ref-type="bibr">2</xref>,<xref rid="B3-toxins-09-00342" ref-type="bibr">3</xref>], with the most important being the loss of muscle mass leading to limb dysfunction or amputation as a result of myonecrosis, dermonecrosis and severe edema that induces ischemia [<xref rid="B3-toxins-09-00342" ref-type="bibr">3</xref>]. The main toxins implicated in these effects are snake venom metalloproteinases (SVMPs) and PLA<sub>2</sub>s [<xref rid="B4-toxins-09-00342" ref-type="bibr">4</xref>,<xref rid="B5-toxins-09-00342" ref-type="bibr">5</xref>]. Proteomic analyses have shown that <italic>B. asper</italic> venom contains at least seven protein families including disintegrin, phospholipases A<sub>2</sub>, serine proteinases, <italic>C</italic>-type lectins, cysteine-rich secretory proteins (CRISP), <italic>L</italic>-amino acid oxidase, and Zn<sup>2+</sup>-dependent metalloproteinases of which PLA<sub>2</sub> are an important group [<xref rid="B6-toxins-09-00342" ref-type="bibr">6</xref>]. PLA<sub>2</sub>, which hydrolyze phospholipids at the <italic>sn</italic>-2 position to release fatty acids and form lysophospholipids [<xref rid="B7-toxins-09-00342" ref-type="bibr">7</xref>], can cause myotoxicity, edema, neurotoxicity, cardiotoxicity and hemolysis, in addition to affecting coagulation, platelet aggregation and showing antibacterial activity [<xref rid="B8-toxins-09-00342" ref-type="bibr">8</xref>].</p><p>Based on the amino acid sequence and pattern of disulfide bonds, snake venom PLA<sub>2</sub> have been classified in two groups: Group I PLA<sub>2</sub> found in venoms of the Elapidae and Hydrophidae and Group II PLA<sub>2</sub> present in the family Viperidae [<xref rid="B9-toxins-09-00342" ref-type="bibr">9</xref>]. PLA<sub>2</sub>s of the latter group are divided into two subgroups: Asp49 PLA<sub>2</sub>s that include catalytically active isoforms and Lys49 PLA<sub>2</sub>s devoid of enzymatic activity [<xref rid="B4-toxins-09-00342" ref-type="bibr">4</xref>]. Asp49 PLA<sub>2</sub>s display a wide range of isoelectric points, from acidic to basic, with the acidic isoforms usually having greater catalytic activity but less toxicity than basic PLA<sub>2</sub>s [<xref rid="B10-toxins-09-00342" ref-type="bibr">10</xref>,<xref rid="B11-toxins-09-00342" ref-type="bibr">11</xref>]. Snake venom acidic PLA<sub>2</sub>s have not been studied as extensively as other PLA<sub>2</sub>s and many of those that have been characterized have been described as non-myotoxic and are involved in pharmacological effects such as hypotension and the inhibition of platelet aggregation [<xref rid="B12-toxins-09-00342" ref-type="bibr">12</xref>]. In this paper, we describe the isolation and characterization of a myotoxic acidic PLA<sub>2</sub> (BaCol PLA<sub>2</sub>) from <italic>B. asper</italic> venom.</p></sec><sec id="sec2-toxins-09-00342"><title>2. Results</title><sec id="sec2dot1-toxins-09-00342"><title>2.1. Isolation, Determination of Molecular Mass, Sequencing and Modeling of BaCol PLA<sub>2</sub></title><p>Fractionation of <italic>B. asper</italic> venom by RP-HPLC resulted in 16 major peaks (<xref ref-type="fig" rid="toxins-09-00342-f001">Figure 1</xref>A) that were collected and screened for PLA<sub>2</sub> activity. Peak 6 (retention time: 67.48 min) showed high PLA<sub>2</sub> activity. Analytical chromatography of this peak by RP-HPLC resulted in a single symmetric peak. SDS-PAGE of the purified protein under reducing conditions showed a single band migrating at ~14.5 kDa (<xref ref-type="fig" rid="toxins-09-00342-f001">Figure 1</xref>B) with an isoelectric point (pI) of 4.4 based on isoelectric focusing (<xref ref-type="fig" rid="toxins-09-00342-f001">Figure 1</xref>C). The molecular mass obtained by ESI-Q-ToF was 14,180.69 Da (<xref ref-type="fig" rid="toxins-09-00342-f002">Figure 2</xref>A,B). This protein was named BaCol PLA<sub>2</sub>.</p><p>The first 25 amino acids of the <italic>N</italic>-terminal region were determined by Edman degradation. This sequence was used to design the primers to obtain the corresponding cDNA from <italic>B. asper</italic> venom gland mRNA. The cDNA encoded a polypeptide 124 amino acids long (<xref ref-type="fig" rid="toxins-09-00342-f003">Figure 3</xref>), with the presence of Asp at position 49 of the catalytic dyad (based on the numbering of Renetseder et al. [<xref rid="B13-toxins-09-00342" ref-type="bibr">13</xref>]) and a theoretical pI of 4.5. The <italic>N</italic>-terminal sequence obtained by Edman degradation was identical to that deduced from cDNA (<xref ref-type="fig" rid="toxins-09-00342-f003">Figure 3</xref>). The DNA sequence was deposited under accession number MF319968.</p><p>Alignment of the amino acid sequence with other PLA<sub>2</sub>s is shown in <xref ref-type="fig" rid="toxins-09-00342-f004">Figure 4</xref>. There was a high percentage of identity with a Costa Rican <italic>B. asper</italic> PLA<sub>2</sub> (BaPLA<sub>2</sub>-II; 91%) and with a PLA<sub>2</sub> from <italic>B. jararaca</italic> (BJPLA<sub>2</sub>; 83%), both of which have 124 amino acids. There was 81% identity with BinTX-I, a 138-amino acid (including signal peptide) PLA<sub>2</sub> from <italic>B. insularis</italic>, and BpirPLA<sub>2</sub>-I, a 122-amino acid PLA<sub>2</sub> from <italic>B. pirajai</italic>. Lower identity was observed with PLA<sub>2</sub> from <italic>B. jararacussu</italic> (Bth-A-I-PLA<sub>2</sub>), <italic>B. moojeni</italic> (Bmoo-PLA<sub>2</sub>) and <italic>B. alternatus</italic> (Balt1) (78%, 77% and 74%, respectively), all of which are acidic PLA<sub>2</sub>.</p><p>After National Center for Biotechnology Information Basic Local Alignment Search Tool (NCBI BLAST) the chain <italic>X</italic> of PLA<sub>2</sub> from <italic>Bothrops jararacussu</italic> (PDB ID: 1UMV_X) was chosen as template for our homology modeling process. The template has a resolution of 1.79 &#197;, an identity score of 78%, an <italic>E</italic> value of 7 &#215; 10<sup>&#8722;67</sup> and coverage of 100% with BaCol PLA<sub>2</sub>. Protein modeling yielded a 3D-structure with the general characteristics of venom PLA<sub>2</sub>s, i.e., a calcium-binding loop, two antiparallel helixes, a <italic>&#946;</italic>-wing and a <italic>C</italic>-terminal loop (<xref ref-type="fig" rid="toxins-09-00342-f005">Figure 5</xref>, <xref ref-type="app" rid="app1-toxins-09-00342">Supplementary Materials Figure S1</xref>). The reliability and quality of the structural model was assessed by Procheck. The detailed residue-by-residue stereochemical quality of the BaCol PLA<sub>2</sub> model was found to be good 91.5% in the most favored regions, 7.5% in additional allowed regions, 1% in generously allowed regions (Arg14) and 0% in disallowed regions (<xref ref-type="app" rid="app1-toxins-09-00342">Supplementary Materials Figure S2</xref>).</p><p>The Verify 3D program was used to determine the compatibility of an atomic model (3D) with its own amino acid sequence (1D). This software considers a good score when at least 80% of the amino acids score &#8805;0.2 in the 3D/1D profile; for BaCol PLA<sub>2</sub>, this value was 87.1%, with scores ranging from 0.05 to 0.53 (<xref ref-type="app" rid="app1-toxins-09-00342">Supplementary Materials Figure S3 and Table S1</xref>). The energetic architecture of the protein folds was determined with the program ProSA and yielded a <italic>Z</italic>-score of &#8722;5.2, which is within the range of native conformations for the template (&#8722;4.49) (data not shown). The energy profile of the BaCol PLA<sub>2</sub> predicted model was thus found to be good (<xref ref-type="app" rid="app1-toxins-09-00342">Supplementary Materials Figure S4</xref>).</p></sec><sec id="sec2dot2-toxins-09-00342"><title>2.2. Biological Activities</title><p>The mean of clot formation time in plasma incubated with BaCol PLA<sub>2</sub> was 446 &#177; 31 s, while plasma incubated with PBS (control) clotted after 208 &#177; 30 s (<italic>n</italic> = 4 each; <italic>p</italic> = 0.0007) The indirect hemolytic activity (<xref ref-type="fig" rid="toxins-09-00342-f006">Figure 6</xref>A) and cleavage of the synthetic substrate 4-nitro-3-octanoyloxy-benzoic acid (4-NOBA) (<xref ref-type="fig" rid="toxins-09-00342-f006">Figure 6</xref>B) by BaCol PLA<sub>2</sub> was equal to the complete venom using 15 &#181;g/&#181;L of purified toxin that generated a 26 mm halo and 15 &#181;g/&#181;L of complete venom that caused a 20 mm halo; the same cleavage capacity of 4-NOBA was also evidenced for both. BaCol PLA<sub>2</sub> caused mouse footpad edema, with 5 &#181;g and 20 &#181;g increasing the paw thickness by 45 &#177; 0.17% and 60 &#177; 0.11%, respectively, 1 h after toxin inoculation. Maximum edema was observed after 2 h (<xref ref-type="fig" rid="toxins-09-00342-f006">Figure 6</xref>C; <italic>p</italic> &lt; 0.0001 compared to the control).</p><p>BaCol PLA<sub>2</sub> induced moderate myonecrosis, seen as an increase in plasma creatine kinase (CK) activity 3 h after toxin injection (50 &#181;g/mouse) compared to the control group (<xref ref-type="fig" rid="toxins-09-00342-f007">Figure 7</xref>A). Histopathological analysis confirmed the occurrence of tissue damage (<xref ref-type="fig" rid="toxins-09-00342-f007">Figure 7</xref>B). Compared to control muscle (<xref ref-type="fig" rid="toxins-09-00342-f007">Figure 7</xref>C) where discrete infiltration of neutrophils, mild vascular congestion and absence of necrosis was observed, BACol PLA<sub>2</sub> caused severe, diffuse muscle fiber damage with vacuolization and necrosis of the sarcoplasm (<xref ref-type="fig" rid="toxins-09-00342-f007">Figure 7</xref>D).</p><p>Incubation of U937 cells with BaCol PLA<sub>2</sub> (1.6 &#181;g/&#181;L) resulted in extensive (82%) damage to the cytoplasmic membrane, seen as high intensity fluorescence for PI (<xref ref-type="fig" rid="toxins-09-00342-f008">Figure 8</xref>B,C). The corresponding damage in control cells was 15% (<xref ref-type="fig" rid="toxins-09-00342-f008">Figure 8</xref>A,C), with most of them showing high intensity fluorescence for DIOC<sub>6</sub> and negative fluorescence for PI, indicating that they were still viable. At a BaCol PLA<sub>2</sub> concentration of 0.16 &#181;g/&#181;L, the plasma membrane damage was ~22% (<xref ref-type="fig" rid="toxins-09-00342-f008">Figure 8</xref>D,F); at this concentration, staining with a phytoerythrin-annexin V conjugate detected no phosphatidylserine externalization, indicating there was no early apoptosis. This finding suggested that the mechanism of cell death caused by BaCol PLA<sub>2</sub> was more compatible with necrosis (<xref ref-type="fig" rid="toxins-09-00342-f008">Figure 8</xref>D). <xref ref-type="fig" rid="toxins-09-00342-f008">Figure 8</xref>E shows the annexin V control without BaCol PLA<sub>2</sub>.</p></sec></sec><sec id="sec3-toxins-09-00342"><title>3. Discussion</title><p>Many acidic PLA<sub>2</sub> isolated from snake venoms are devoid of pharmacological activities or toxicity, including myotoxicity [<xref rid="B11-toxins-09-00342" ref-type="bibr">11</xref>,<xref rid="B14-toxins-09-00342" ref-type="bibr">14</xref>,<xref rid="B15-toxins-09-00342" ref-type="bibr">15</xref>]. In this report, we describe the structural and functional characteristics of BaCol PLA<sub>2</sub>, a new acidic myotoxic Asp49 PLA<sub>2</sub> isolated from Colombian <italic>B. asper</italic> venom. The toxin was obtained in a single chromatographic step by RP-HPLC and had a molecular mass of 14,180.69 Da and pI of 4.4. The complete sequence obtained from <italic>B. asper</italic> venom gland cDNA indicated that this protein differed from other acidic PLA<sub>2</sub> previously reported for this species [<xref rid="B11-toxins-09-00342" ref-type="bibr">11</xref>]. BaCol PLA<sub>2</sub> contained Asp at position 48 (position 49 is the catalytic diad, according to the numbering of Renetseder et al. [<xref rid="B13-toxins-09-00342" ref-type="bibr">13</xref>]), and was therefore classified as an Asp49 PLA<sub>2</sub>. We used homology modeling to obtain a hypothetical 3D structure of BaCol PLA<sub>2</sub>. The model obtained was reliable since the stereochemical quality, the compatibility of the 3D structure with the amino acid sequence and the energy profile of the generated model were similar of those described for other acidic PLA<sub>2</sub>s [<xref rid="B14-toxins-09-00342" ref-type="bibr">14</xref>]. In addition, our model showed the conserved residues involved in calcium binding (Tyr28, Gly30, Gly32, His48 and Asp49) and in the catalytic network (His48, Asp99, Tyr52, and Tyr73) [<xref rid="B13-toxins-09-00342" ref-type="bibr">13</xref>]. In common with other snake venom acidic PLA<sub>2</sub> [<xref rid="B7-toxins-09-00342" ref-type="bibr">7</xref>,<xref rid="B12-toxins-09-00342" ref-type="bibr">12</xref>], BaCol PLA<sub>2</sub> had highly conserved amino acids, such as 14 cysteines involved in the formation of seven disulfide bonds.</p><p>BaCol PLA<sub>2</sub> was myotoxic, as shown by an increase in circulating creatine kinase and histological damage (involving fiber contraction, clumping and degeneration) to gastrocnemius muscle fibers. However, myotoxicity is not a consistent characteristic of acidic PLA<sub>2</sub> isolated from <italic>Bothrops</italic> venoms. Thus, whereas acidic PLA<sub>2</sub> such as BinTX-I from <italic>B. insularis</italic> [<xref rid="B12-toxins-09-00342" ref-type="bibr">12</xref>], Bp-PLA<sub>2</sub> from <italic>B. pauloensis</italic> [<xref rid="B16-toxins-09-00342" ref-type="bibr">16</xref>] and BmooTX-I from <italic>B. moojeni</italic> [<xref rid="B17-toxins-09-00342" ref-type="bibr">17</xref>] venoms are myotoxic, others, such as PLA<sub>2</sub>s from <italic>B. jararaca</italic> [<xref rid="B18-toxins-09-00342" ref-type="bibr">18</xref>], Costa Rican <italic>B. asper</italic> [<xref rid="B11-toxins-09-00342" ref-type="bibr">11</xref>], <italic>B. pirajai</italic> [<xref rid="B14-toxins-09-00342" ref-type="bibr">14</xref>] and <italic>B. moojeni</italic> [<xref rid="B19-toxins-09-00342" ref-type="bibr">19</xref>] are not. BaCol PLA<sub>2</sub> showed high identity (91%) with Costa Rican BaspPLA<sub>2</sub>-II; the incomplete identity suggests that variations in some amino acid residues could play an important role in determining the occurrence of myonecrosis.</p><p>Similar results were found with BmooTX-I obtained from <italic>B. moojeni</italic>, in which extensive cellular destruction and abundant leukocitary infiltrate were described and, further displaying contracted and clumped fibers in different stages of degeneration [<xref rid="B17-toxins-09-00342" ref-type="bibr">17</xref>]. Bp-PLA<sub>2</sub> from <italic>B. pauloensis</italic> [<xref rid="B16-toxins-09-00342" ref-type="bibr">16</xref>], whose myotoxicity was confirmed by the increase in the CK activity was similar to induced by whole venom. In the same way, BinTX-I from <italic>B. insularis</italic>, also increased CK activity. Nevertheless, morphological analysis, showed BinTX-I produced less damaged proportion of fibers than the venom [<xref rid="B12-toxins-09-00342" ref-type="bibr">12</xref>].</p><p>BaCol PLA<sub>2</sub> was highly edematogenic, with the peak response occurring 2 h after toxin injection. This finding agrees with other acidic PLA<sub>2</sub> with which BaCol PLA<sub>2</sub> shares considerable identity [<xref rid="B10-toxins-09-00342" ref-type="bibr">10</xref>,<xref rid="B11-toxins-09-00342" ref-type="bibr">11</xref>,<xref rid="B12-toxins-09-00342" ref-type="bibr">12</xref>,<xref rid="B14-toxins-09-00342" ref-type="bibr">14</xref>,<xref rid="B19-toxins-09-00342" ref-type="bibr">19</xref>].</p><p>BaCol PLA<sub>2</sub> was cytotoxic to U937 lymphocytes at concentrations ranging from 0.016 &#181;g/&#181;L (data not shown) to 1.6 &#181;g/&#181;L after 24 h. Santos Filho et al. [<xref rid="B17-toxins-09-00342" ref-type="bibr">17</xref>] reported that BmooTX-I was able to hydrolyze cell membrane phosphatidylcholine to release free fatty acids and lysophospholipids, resulting in cellular damage. In contrast, Bl-PLA<sub>2</sub> from <italic>Bothrops leucurus</italic> did not affect the viability of human peripheral blood mononuclear cells [<xref rid="B20-toxins-09-00342" ref-type="bibr">20</xref>]. Similarly, BaspPLA<sub>2</sub>-II did not damage the cell membrane of C2C12 skeletal muscle myoblasts in culture [<xref rid="B11-toxins-09-00342" ref-type="bibr">11</xref>]. Staining of U937 lymphocytes with annexin V and PI revealed no early apoptosis (no exposure of phosphatidylserine), indicating that cell death was by necrosis rather than apoptosis. Mora et al. [<xref rid="B21-toxins-09-00342" ref-type="bibr">21</xref>] reported that a basic Lys49 PLA<sub>2</sub> from Costa Rican <italic>B. asper</italic> induced apoptosis at concentrations of 5&#8211;25 &#181;g/mL, whereas necrosis was observed at a concentration of 50 &#181;g/mL. In contrast, our findings revealed no marked differences in the effects seen with two concentrations of BaCol PLA<sub>2</sub> (0.16 &#956;g/&#956;L and 1.6 &#181;g/&#956;L).</p><p>BaCol PLA<sub>2</sub> showed anticoagulant activity based on prolongation of the plasma clotting time. Anticoagulant activity has not generally been evaluated among other acidic PLA<sub>2</sub>, except for BaPLA<sub>2</sub>-II, which was found to have no such activity [<xref rid="B11-toxins-09-00342" ref-type="bibr">11</xref>]. Compared to the strong anticoagulant activity of basic PLA<sub>2</sub>s, that of BaCol PLA<sub>2</sub> was quite weak. This discrepancy could be explained by the finding that in PLA<sub>2</sub>s with high anticoagulant activity the putative anticoagulant site located between residues 54 and 77 is positively charged, contrary to PLA<sub>2</sub> with moderate or low anticoagulant activity, in which there is a predominance of negative or neutral charges in this region [<xref rid="B22-toxins-09-00342" ref-type="bibr">22</xref>]. This explanation based on structure agrees with the presence of four aspartic acid and two glutamic acid in this segment in the amino acid sequence of BaCol PLA<sub>2</sub>. In <xref ref-type="table" rid="toxins-09-00342-t001">Table 1</xref> can be observed the comparative characteristics of BaCol PLA<sub>2</sub> and other acidic PLA<sub>2</sub> describe before.</p><p>In Colombia there are few studies for <italic>B. asper</italic> acidic myotoxic PLA<sub>2</sub> and therefore it is necessary to deepen in order to understand better its action mechanism and its relationship with the effects induced by venom.</p></sec><sec id="sec4-toxins-09-00342"><title>4. Materials and Methods</title><sec id="sec4dot1-toxins-09-00342"><title>4.1. Venom</title><p><italic>Bothrops asper</italic> venom from central Magdalena in Antioquia was donated by the Antioquia University serpentarium. The pool of venom was obtained by manual milking of 30 adult specimens. The venom was centrifuged, lyophilized and frozen at &#8722;70 &#176;C until used.</p></sec><sec id="sec4dot2-toxins-09-00342"><title>4.2. Animals</title><p>Male Swiss-Webster mice were supplied by the Animal House (Sede de Investigacion Universitaria&#8211;SIU) of the Universidad de Antioquia and maintained under standard conditions with access to food and water <italic>ad libitum</italic>. The experimental protocol was approved by the institutional Committee for the Use and Care of Research Animals at the Universidad de Antioquia (license nos. 70 (2011) and 102 (2016)).</p></sec><sec id="sec4dot3-toxins-09-00342"><title>4.3. Isolation of BaCol PLA<sub>2</sub></title><p>Venom (10 mg) was dissolved in 200 &#181;L of 0.1% trifluoroacetic acid (TFA; solvent A), centrifugated and applied to a reverse-phase high performance liquid chromatography (RP-HPLC) C18 semipreparative column (250 &#215; 10 mm, 5 &#956;m particle; Restek, Bellefonte, PA, USA), using a Shimadzu Prominence-20A chromatograph. Elution was performed at 2 mL/min by applying solution B (acetonitrile, containing 0.1% TFA) as follows: 5% B for 5 min, 15% B over 15 min, 45% over 75 min, 70% B over 85 min, 90 min 70%. The elution profile was monitored at 215 nm in a UV/VIS photodiode array detector (Shimadzu, Kyoto, Japan). The peaks were collected and evaluated by SDS PAGE on a 12% polyacrylamide gel and peaks with electrophoretic bands of ~15 kDa were subsequently screened for hemolytic activity. Of the peaks obtained, only two had hemolysis halo greater than 20 mm, but only one was located around 15 kDa and that is the reason to choose it. The enzymatically active fraction was subsequently applied to a liquid chromatography (RP-HPLC) C18 analytical column (250 &#215; 4.6 mm; Restek, Bellefonte, PA, USA), using a Shimadzu Prominence-20A chromatograph. Elution was performed at 1 mL/min by applying solution B (acetonitrile, containing 0.1% TFA) as follows: 0% B for 0 min, 100% B over 30 min. The elution profile was monitored at 215 nm in a UV/VIS photodiode array detector (Shimadzu, Kyoto, Japan).</p><p>The electrophoretic homogeneity of BaCol PLA<sub>2</sub> was evaluated by SDS-PAGE. For this, 20 &#181;g of protein was loaded onto a 12% polyacrylamide gel and run in a Mini-Protean Tetra<sup>&#174;</sup> electrophoresis system (Bio-Rad, Hercules, CA, USA) at 150 V. The gel was subsequently stained with Coomassie blue <italic>R</italic>-250 [<xref rid="B23-toxins-09-00342" ref-type="bibr">23</xref>].</p></sec><sec id="sec4dot4-toxins-09-00342"><title>4.4. Molecular Mass and N-Terminal Determination</title><p>Protein purity and molecular mass were also examined by ESI-Q-ToF mass spectrometry using a MicrQ-TOF III mass spectrometer (Bruker Daltonics, Billerica, MA, USA) coupled to an LC-20AT liquid chromatograph (Shimadzu, Kyoto, Japan). Two mobile phases were used: water (A) and acetonitrile (B), both in the presence of 0.1% (<italic>v</italic>/<italic>v</italic>) formic acid. Chromatographic runs were done on a C18 reverse-phase column (4.5 mm &#215; 100 mm, 1.8 &#956;m). The elution conditions were consisted of a 0&#8211;85% linear gradient of solvent B for 60 min at a flow rate of 0.2 mL/min. The sample column and automatic applicator were held at 25 &#176;C and 10 &#176;C, respectively. The mass spectrometer was operated at 4.5 kV with a solvation temperature of 180 &#176;C, positive mode with an ionization interval between 100 m/z and 3000 m/z, a nitrogen flow of 6 L/min and pressure of 0.8 bars. The data were processed using Bruker Data Analysis software (version 3.3, Billerica, MA, USA, 2011).</p><p>The <italic>N</italic>-terminal sequence was determined using a Shimadzu automatic protein sequencer (PPSQ-23A model). An aliquot of the sample (~1 mg/mL) was applied to the sequencer and the sequence was determined by Edman degradation [<xref rid="B24-toxins-09-00342" ref-type="bibr">24</xref>]. The <italic>N</italic>-terminal sequence was subsequently aligned with other snake venom PLA<sub>2</sub>s using BLAST [<xref rid="B25-toxins-09-00342" ref-type="bibr">25</xref>] and MultAlin [<xref rid="B26-toxins-09-00342" ref-type="bibr">26</xref>] programs.</p></sec><sec id="sec4dot5-toxins-09-00342"><title>4.5. cDNA and Nucleotide Sequencing</title><p>A venomous gland from a dead adult specimen of <italic>B. asper</italic> from the serpentarium of the Universidad de Antioquia was used to obtain the complete sequence of the toxin. The gland total RNA was extracted with QIAzol<sup>&#174;</sup> according to the manufacturer&#8217;s instructions (Qiagen, Hilden, Germany). The RNA was subsequently retrotranscribed using Superscript III enzyme (Invitrogen<sup>&#174;</sup>) as recommended by the manufacturer (Invitrogen Corporation, Carlsbad, CA, USA). The mRNA was transformed into cDNA using a dNTP mix and specifically designed <italic>N</italic>-terminal-based primers: external primer 5&#8242;-GTTTGGCCAGATGATGAGCG-3&#8242; and internal primer 5&#8242;-GGCGATGATCCGTGCAAAAA-3&#8242;. The cDNA was cloned into the vector pGEM-<italic>T</italic> Easy (Promega, Madison, WI, USA) and DH5-<italic>&#945; E. coli</italic> were transformed. PCR was used to detect the presence of the vector with the toxin sequence. The plasmid was obtained from these transformed colonies using the construct and a QIA prep<sup>&#174;</sup> spin miniprep kit (Qiagen, Hilden, Germany). The product of this extraction was sequenced (Macrogen, Seoul, Korea) to certify that it corresponded to whole plasmids with the gene inserted in the multiple cloning site. Sequencing was done from the vector T7 and SP6 promoters. The DNA sequence data were analyzed and translated into the amino acid sequence using Mega 6 software [<xref rid="B27-toxins-09-00342" ref-type="bibr">27</xref>]. Protein sequence homology in the Swiss-Prot database was searched using FASTA3 [<xref rid="B28-toxins-09-00342" ref-type="bibr">28</xref>] and sequence alignments were generated with CLUSTAL W 2.1. The theoretical isoelectric point was calculated with ExPASy [<xref rid="B29-toxins-09-00342" ref-type="bibr">29</xref>].</p></sec><sec id="sec4dot6-toxins-09-00342"><title>4.6. Bidimensional Electrophoresis and Determination of Isoelectric Point</title><p>For the first dimension, 30 &#181;g of BaCol PLA<sub>2</sub> was applied to a 7 cm long immobilized pH gradients strip (pH 3&#8211;10). The strip was rehydrated overnight at room temperature in 125 &#181;L of rehydration solution containing 8 M urea, 2% (<italic>w</italic>/<italic>v</italic>) CHAPS, 1% of immobilized pH gradient (IPG) buffer solution, 19 nM dithiothreitol (DTT) and bromophenol blue. Isoelectric focusing was done in three steps: first step&#8212;500 V for 30 min, second step&#8212;1000 V for 30 min, and third step&#8212;5000 V for 2 h. The strip was subsequently equilibrated for 20 min in 19 mM DTT, 50 mM Tris, 6 M urea, 30% glycerol (<italic>v</italic>/<italic>v</italic>) and 2% SDS (<italic>w</italic>/<italic>v</italic>) followed by a further 20 min in the same solution, except that DTT was replaced by 0.2 M iodioacetamide. For the second dimension, the isoelectric focusing strip was place on top of a 10% polyacrylamide gel (10 &#215; 10 cm, 1.5 mm thick). Electrophoresis was done at room temperature in two steps (10 mA per gel for 15 min and then 20 mA per gel for 1 h) and the gel then stained with Coomassie Brilliant Blue. The biodimensional gel was digitized using an ImageScanner III scanner (GE Healthcare Life Sciences, Issaquah, WA, USA) in transmission mode and the image was analyzed using Image Master 2D Platinum v 7.05 (GE Healthcare, Little Chalfont, UK) software to determine the isoelectric point.</p></sec><sec id="sec4dot7-toxins-09-00342"><title>4.7. Molecular Modeling</title><p>The NCBI Basic Local Alignment Search Tool (BLAST) for sequence similarities was used to search the crystal structures of the closest homologs available in the Brookhaven Protein Data Bank (PDB). The results retrieved by NCBI BLAST identified chain <italic>X</italic> of PLA<sub>2</sub> from <italic>Bothrops jararacussu</italic> (PDB ID: 1WMV_X) with a resolution of 1.79 &#197; as a suitable template with an identity score of 78%, an E value of 7 &#215; 10<sup>&#8722;67</sup> and coverage of 100%. The three-dimensional model of BaCol PLA<sub>2</sub>s was obtained using the program Modeller (9.17) [<xref rid="B30-toxins-09-00342" ref-type="bibr">30</xref>,<xref rid="B31-toxins-09-00342" ref-type="bibr">31</xref>]. This program is completely automated and capable of generating energy minimized protein models by satisfying spatial restraints on bond distances and dihedral angles extracted from the template PDB file. Modeller performs automatic loop modeling and model optimization. Numerous runs of Modeller were used to generate the most plausible model. The stereochemical excellence of the protein structure and overall structural geometry were confirmed using Procheck [<xref rid="B32-toxins-09-00342" ref-type="bibr">32</xref>]. The energy of residues was checked with ProSA using the web service ProSA-web [<xref rid="B33-toxins-09-00342" ref-type="bibr">33</xref>,<xref rid="B34-toxins-09-00342" ref-type="bibr">34</xref>]. Verify 3D software was used to determine the compatibility of an atomic model (3D) with its own amino acid sequence (1D) by assigning a structural class based on its location and environment (<italic>&#945;</italic>, <italic>&#946;</italic>, loop, polar, non-polar, etc.), as well as by comparing the results with good database structures [<xref rid="B35-toxins-09-00342" ref-type="bibr">35</xref>].</p></sec><sec id="sec4dot8-toxins-09-00342"><title>4.8. PLA<sub>2</sub> Activity</title><p>PLA<sub>2</sub> activity was evaluated in vitro by indirect hemolysis on agar gel containing human erythrocytes and egg yolk [<xref rid="B36-toxins-09-00342" ref-type="bibr">36</xref>] and by cleavage of the synthetic substrate 4-NOBA [<xref rid="B37-toxins-09-00342" ref-type="bibr">37</xref>,<xref rid="B38-toxins-09-00342" ref-type="bibr">38</xref>], the latter modified for 96-well plates. For the latter assay, the standard assay mixture contained 200 &#956;L of buffer (10 mM Tris-HCl, 10 mM CaCl<sub>2</sub>, 100 mM NaCl, pH 8.0), 20 &#956;L of 4-NOBA, 20 &#956;L of water and 20 &#956;L of PLA<sub>2</sub> (1 &#956;g/&#956;L) in a final volume of 260 &#956;L. After adding BaCol PLA<sub>2</sub> (20 &#956;g), the mixture was incubated at 37 &#176;C for 60 min after which the absorbance was determined at 405 nm using a multi-well plate reader (Awareness, Stat Fax 3200, Westport, CT, USA). The activity was expressed as the increase in absorbance/min during the linear phase of the reaction. All the assays were done in triplicate. <italic>Bothrops asper</italic> venom and synthetic substrate 4-NOBA without toxin were used as positive and negative controls, respectively.</p></sec><sec id="sec4dot9-toxins-09-00342"><title>4.9. Edematogenic Activity</title><p>BaCol PLA<sub>2</sub> (5 &#956;g and 20 &#956;g) diluted in 50 &#956;L of phosphate-buffered saline (PBS) was injected subcutaneously in the right hind paw footpad and control mice were injected with 50 &#956;L of PBS (<italic>n</italic> = 4 mice/group, experiment was performed in duplicate). Footpad thickness was measured (in mm) with calipers 1, 2 and 3 h after toxin injection. Hind paw footpad thickness was measured prior to the inoculations and edema was expressed as the increase of this measure in each of the three moments with respect to the initial measurement [<xref rid="B39-toxins-09-00342" ref-type="bibr">39</xref>].</p></sec><sec id="sec4dot10-toxins-09-00342"><title>4.10. Myotoxicity</title><p>Mice were inoculated in the right gastrocnemius muscle with 0.9% NaCl (100 &#181;L; control; <italic>n</italic> = 4) or BaCol PLA<sub>2</sub> (50 &#181;g in 100 &#181;L of 0.9% NaCl; <italic>n</italic> = 4). After 3 h, a 70 &#181;L blood sample was collected from the tail vein into heparinized capillaries. The plasma was separated and used to quantify CK activity (CK-NAC UV, Wiener Lab<sup>&#174;</sup>, Rosario, Argentina) according to the manufacturer&#8217;s instructions, with the final absorbance being measured at 280 nm [<xref rid="B40-toxins-09-00342" ref-type="bibr">40</xref>,<xref rid="B41-toxins-09-00342" ref-type="bibr">41</xref>]. The gastrocnemius muscle was dissected and fragments were processed for histopathological analysis. Sections 4 &#181;m thick were stained with hematoxylin and eosin and examined for myonecrosis, edema, congestion and leukocyte infiltrate. The extent of myonecrosis was calculated by examining 3 non-overlapping regions in each cross-sections/muscle or mouse (4 mice/group) as the percentage of the examined area corresponding to necrotic fibers, (myofibril disorganization, delta lesions, vacuolation).</p></sec><sec id="sec4dot11-toxins-09-00342"><title>4.11. Anticoagulant Activity</title><p>The effect of BaCol PLA<sub>2</sub> on the clotting time of human plasma was examined by preincubating 20 &#956;g of enzyme (in 50 &#956;L of PBS) with 500 &#956;L of human citrated plasma for 10 min at 37 &#176;C, in duplicate. Subsequently, 100 &#956;L of 0.25 M CaCl<sub>2</sub> was added and time to clot (in seconds) was recorded manually. Plasma aliquots preincubated with PBS were used as controls [<xref rid="B36-toxins-09-00342" ref-type="bibr">36</xref>]. The assay was performed in triplicate.</p></sec><sec id="sec4dot12-toxins-09-00342"><title>4.12. Cell Viability and Cell Death</title><p>U937 cells were used to assess alterations on the mitochondrial permeability transition (MPT) and damage to the cell membrane. The cells were suspended in RPMI 1640 medium supplemented with 10% fetal bovine serum and then plated at a density of 300.000 cells/well (total volume/well: 300 &#956;L) followed by incubation at 37 &#176;C for 24 h. DIOC<sub>6</sub> and propidium iodide (PI) were used to determine the MPT and cell membrane damage, respectively, by flow cytometry (FACSCanto II). BaCol PLA<sub>2</sub> cytotoxicity was evaluated at concentrations ranging from 0.016 &#956;g/&#956;L to 1.6 &#956;g/&#956;L after 24 h. The cells that showed high intensity fluorescence for DIOC<sub>6</sub> and negative fluorescence for PI were classified as viable, whereas those with high intensity fluorescence for PI were considered to be dead (as a consequence of damage to the cytoplasmic membrane). To determine the type of cell death induced by PLA<sub>2</sub>, cells were suspended in medium containing PI and annexin V (Invitrogen<sup>&#174;</sup>, Carlsbad, CA, USA). Cells were considered apoptotic when they showed positive staining for annexin V and negative staining for PI; non-apoptotic cells showed no staining for either dye. Cells in the early stages of apoptosis were positive for annexin V and negative for PI, whereas necrotic cells showed double-positive staining. Cells suspended in RPMI 1640 and stains without PLA<sub>2</sub>, were used as negative controls in both experiments.</p></sec><sec id="sec4dot13-toxins-09-00342"><title>4.13. Statistical Analysis</title><p>Numerical data were expressed as the mean &#177; SD. Statistical comparisons were done using Student&#8217;s <italic>t</italic>-test or one-way ANOVA followed by the Bonferroni test, with <italic>p</italic> &lt; 0.05 indicating significance. All data analyses were done using the software GraphPad Prism 5.01 version for Windows (GraphPad Software, San Diego, CA, USA, 2007).</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank Ronald Pel&#225;ez S&#225;nchez of the Biology and Infectious Diseases Control group of the University of Antioquia for his valuable help in obtaining the sequence of BaCol PLA<sub>2</sub>, the Center for the Study of Venoms and Venomous Animals (CEVAP) of S&#227;o Paulo State University (UNESP), Botucatu, SP, Brazil for providing the facilities for 2D-electrophoresis and mass spectrometric analysis and Stephen Hyslop of Department of Pharmacology, Faculty of Medical Sciences of Campinas (UNICAMP) for his help in reviewing the english language in this paper. This project was funded with resources from the Committee for the Development of Research University of Antioquia.</p></ack><app-group><app id="app1-toxins-09-00342"><title>Supplementary Materials</title><p>The following are available online at <uri xlink:href="www.mdpi.com/2072-6651/9/11/342/s1">www.mdpi.com/2072-6651/9/11/342/s1</uri>, Figure S1: Overlay of the proposed structure of BaCol PLA<sub>2</sub> (Cyan) with the template structure (PDB ID: 1UMV_X, Purple). Green sphere represents a Ca<sup>2+</sup> ion; Figure S2: Ramachandran plot of modeled BaCol PLA<sub>2</sub>. The favored and most favored region is red and brown respectively. Yellow is the generally allowed and disallowed regions is pale yellow; Figure S3: Verify-3D analysis. Green-dashed line represents the limit score of 0.2. Positive scores suggest that the residues are compatible with their environments in the model build forBaCol PLA<sub>2</sub>. The lowest and the highest values are shown; Table S1: Residues with a score under 0.2; Figure S4: ProSA energy plot calculated for the BaCol PLA<sub>2</sub> homology model. The energy plot displayed byProSA shows the local model quality by plotting energies in function of the amino acid sequence position. Positive values correspond to problematic or erroneous parts of a model. When the fragment of 10 residues was evaluated, most of them were in the negative region. However, when a fragment of 40 residues was evaluated none of the residues is outside of the negative region.</p><supplementary-material content-type="local-data" id="toxins-09-00342-s001"><media xlink:href="toxins-09-00342-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Silvia Posada Arias purified the PLA<sub>2</sub> by HPLC, ran SDS-PAGE, assayed the PLA<sub>2</sub> activity, examined the edema, myotoxicity and anticoagulant activities, as well as assessing cell viability and cDNA sequencing; participated in data analysis and discussion and in organizing and writing the article; Paola Rey-Su&#225;rez helped with HPLC, SDS-PAGE, PLA<sub>2</sub> assay and determination of the myotoxicity and anticoagulant activity, in addition to preparing the figures for the article; Andr&#233;s Pere&#225;&#241;ez J helped with the PLA<sub>2</sub> assay and did the molecular modeling of the protein; Cristian Acosta prepared the cDNA and did the sequencing (primer design, PCR, cloning in <italic>E. coli</italic>, alignment); Mauricio Rojas designed and performed the flow cytometry, cell viability and cell death experiments; Lucilene Delazari dos Santos did the 2D electrophoresis and mass spectrometry; Rui Seabra Ferreira Jr determined the <italic>N</italic>-terminal by Edman degradation. Vitelbina N&#250;&#241;ez participated in various experiments (PLA<sub>2</sub> assay, edema formation, myotoxicity and anticoagulant activity). All authors discussed the results and read and agreed with the final version of the manuscript prior to submission.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no potential conflicts of interest regarding this manuscript. The founding sponsors had no role in the design of the study, in the collection, analysis or interpretation of the data, in the writing of the manuscript, or in the decision to publish the results.</p></notes><ref-list><title>References</title><ref id="B1-toxins-09-00342"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarmiento</surname><given-names>K.</given-names></name></person-group><article-title>Aspectos biom&#233;dicos del accidente of&#237;dico</article-title><source>Univ. Med.</source><year>2012</year><volume>53</volume><fpage>68</fpage><lpage>82</lpage></element-citation></ref><ref id="B2-toxins-09-00342"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Le&#243;n</surname><given-names>L.</given-names></name></person-group><source>Informe Final del Evento Accidente Of&#237;dico</source><publisher-name>Instituto Nacional de Salud</publisher-name><publisher-loc>Bogot&#225;, Colombia</publisher-loc><year>2015</year></element-citation></ref><ref id="B3-toxins-09-00342"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otero</surname><given-names>P.</given-names></name></person-group><article-title>Epidemiological, clinical and therapeutic aspects of <italic>Bothrops asper</italic> bites</article-title><source>Toxicon</source><year>2009</year><volume>54</volume><fpage>998</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2009.07.001</pub-id><?supplied-pmid 19591857?><pub-id pub-id-type="pmid">19591857</pub-id></element-citation></ref><ref id="B4-toxins-09-00342"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guti&#233;rrez</surname><given-names>J.M.</given-names></name><name><surname>Lomonte</surname><given-names>B.</given-names></name></person-group><article-title>Phospholipase A<sub>2</sub> myotoxins from <italic>Bothrops</italic> snake venoms</article-title><source>Toxicon</source><year>1995</year><volume>33</volume><fpage>1405</fpage><lpage>1424</lpage><pub-id pub-id-type="doi">10.1016/0041-0101(95)00085-Z</pub-id><pub-id pub-id-type="pmid">8744981</pub-id></element-citation></ref><ref id="B5-toxins-09-00342"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera</surname><given-names>C.</given-names></name><name><surname>Kele</surname><given-names>J.</given-names></name><name><surname>Feoli</surname><given-names>M.A.</given-names></name><name><surname>Esclante</surname><given-names>T.</given-names></name><name><surname>Rucavado</surname><given-names>A.</given-names></name><name><surname>Guit&#233;rrez</surname><given-names>J.M.</given-names></name></person-group><article-title>Muscle tissue damage induced by the venom of <italic>Bothrops asper</italic>: Identification of early and late pathological events through proteomic analysis</article-title><source>PLoS Negl. Trop. Dis.</source><year>2016</year><volume>10</volume><elocation-id>e0004599</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0004599</pub-id><?supplied-pmid 27035343?><pub-id pub-id-type="pmid">27035343</pub-id></element-citation></ref><ref id="B6-toxins-09-00342"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alape-Gir&#243;n</surname><given-names>A.</given-names></name><name><surname>Flores-D&#237;az</surname><given-names>M.</given-names></name><name><surname>Sanz</surname><given-names>L.</given-names></name><name><surname>Madrigal</surname><given-names>M.</given-names></name><name><surname>Escolano</surname><given-names>J.</given-names></name><name><surname>Sasa</surname><given-names>M.</given-names></name><name><surname>Calvete</surname><given-names>J.J.</given-names></name></person-group><article-title>Studies on the venom proteome of <italic>Bothrops asper</italic>: Perspectives and applications</article-title><source>Toxicon</source><year>2009</year><volume>54</volume><fpage>938</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2009.06.011</pub-id><?supplied-pmid 19539636?><pub-id pub-id-type="pmid">19539636</pub-id></element-citation></ref><ref id="B7-toxins-09-00342"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>T.S.</given-names></name><name><surname>Georgieva</surname><given-names>D.</given-names></name><name><surname>Genov</surname><given-names>N.</given-names></name><name><surname>Murakami</surname><given-names>M.</given-names></name><name><surname>Sinha</surname><given-names>M.</given-names></name><name><surname>Kumar</surname><given-names>R.</given-names></name><name><surname>Kaur</surname><given-names>P.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Dey</surname><given-names>S.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Enzymatic toxins from snake venom: Structural characterization and mechanism of catalysis</article-title><source>FEBS J.</source><year>2011</year><volume>278</volume><fpage>4544</fpage><lpage>4576</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2011.08115.x</pub-id><?supplied-pmid 21470368?><pub-id pub-id-type="pmid">21470368</pub-id></element-citation></ref><ref id="B8-toxins-09-00342"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soares</surname><given-names>A.M.</given-names></name><name><surname>Fontes</surname><given-names>M.R.M.</given-names></name><name><surname>Giglio</surname><given-names>J.R.</given-names></name></person-group><article-title>Phospholipase A<sub>2</sub> myotoxins from <italic>Bothrops</italic> snake venoms: Structure-function relationship</article-title><source>Curr. Org. Chem.</source><year>2004</year><volume>8</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.2174/1385272043369610</pub-id></element-citation></ref><ref id="B9-toxins-09-00342"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaloske</surname><given-names>R.</given-names></name><name><surname>Dennis</surname><given-names>E.</given-names></name></person-group><article-title>The phospholipase A<sub>2</sub> superfamily and its group numbering system</article-title><source>Biochim. Biophys. Acta</source><year>2006</year><volume>1761</volume><fpage>1246</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2006.07.011</pub-id><?supplied-pmid 16973413?><pub-id pub-id-type="pmid">16973413</pub-id></element-citation></ref><ref id="B10-toxins-09-00342"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andri&#227;o-Escarso</surname><given-names>S.</given-names></name><name><surname>Soares</surname><given-names>A.</given-names></name><name><surname>Fontes</surname><given-names>M.</given-names></name><name><surname>Fuly</surname><given-names>A.</given-names></name><name><surname>Corr&#234;a</surname><given-names>F.</given-names></name><name><surname>Rosa</surname><given-names>J.</given-names></name><name><surname>Greene</surname><given-names>L.</given-names></name><name><surname>Giglio</surname><given-names>J.</given-names></name></person-group><article-title>Structural and functional characterization of an acidic platelet aggregation inhibitor and hypotensive phospholipase A<sub>2</sub> from <italic>Bothrops jararacussu</italic> snake venom</article-title><source>Biochem. Pharmacol.</source><year>2002</year><volume>64</volume><fpage>723</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1016/S0006-2952(02)01210-8</pub-id><pub-id pub-id-type="pmid">12167491</pub-id></element-citation></ref><ref id="B11-toxins-09-00342"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#225;ndez</surname><given-names>J.</given-names></name><name><surname>Guti&#233;rrez</surname><given-names>J.M.</given-names></name><name><surname>Angulo</surname><given-names>Y.</given-names></name><name><surname>Sanz</surname><given-names>L.</given-names></name><name><surname>Ju&#225;rez</surname><given-names>P.</given-names></name><name><surname>Calvete</surname><given-names>J.</given-names></name><name><surname>Lomonte</surname><given-names>B.</given-names></name></person-group><article-title>Isolation of an acidic phospholipase A<sub>2</sub> from the venom of the snake <italic>Bothrops asper</italic> of Costa Rica: biochemical and toxicological characterization</article-title><source>Biochimie</source><year>2010</year><volume>92</volume><fpage>273</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2009.12.006</pub-id><?supplied-pmid 20026168?><pub-id pub-id-type="pmid">20026168</pub-id></element-citation></ref><ref id="B12-toxins-09-00342"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cogo</surname><given-names>J.</given-names></name><name><surname>Lilla</surname><given-names>S.</given-names></name><name><surname>Souza</surname><given-names>G.</given-names></name><name><surname>Hyslop</surname><given-names>S.</given-names></name><name><surname>De Nucci</surname><given-names>G.</given-names></name></person-group><article-title>Purification, sequencing and structural analysis of two acidic phospholipases A<sub>2</sub> from the venom of <italic>Bothrops insularis</italic> (jararaca ilhoa)</article-title><source>Biochimie</source><year>2006</year><volume>88</volume><fpage>1947</fpage><lpage>1959</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2006.10.006</pub-id><?supplied-pmid 17140721?><pub-id pub-id-type="pmid">17140721</pub-id></element-citation></ref><ref id="B13-toxins-09-00342"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renetseder</surname><given-names>R.</given-names></name><name><surname>Brunie</surname><given-names>S.</given-names></name><name><surname>Dijkstrat</surname><given-names>B.W.</given-names></name><name><surname>Drentht</surname><given-names>J.</given-names></name><name><surname>Sigler</surname><given-names>P.B.</given-names></name></person-group><article-title>A comparison of the crystal structures of phospholipase A<sub>2</sub> from bovine pancreas and <italic>Crotalus atrox</italic> venom</article-title><source>J. Biol. Chem.</source><year>1985</year><volume>260</volume><fpage>11627</fpage><lpage>11634</lpage><?supplied-pmid 4044572?><pub-id pub-id-type="pmid">4044572</pub-id></element-citation></ref><ref id="B14-toxins-09-00342"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teixeira</surname><given-names>S.</given-names></name><name><surname>Silveira</surname><given-names>L.</given-names></name><name><surname>Da Silva</surname><given-names>F.</given-names></name><name><surname>Marchi-Salvador</surname><given-names>D.</given-names></name><name><surname>Silva</surname><given-names>F.</given-names><suffix>Jr.</suffix></name><name><surname>Izidoro</surname><given-names>L.</given-names></name><name><surname>Fuly</surname><given-names>A.</given-names></name><name><surname>Juliano</surname><given-names>M.</given-names></name><name><surname>Dos Santos</surname><given-names>C.</given-names></name><name><surname>Murakami</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Molecular characterization of an acidic phospholipase A<sub>2</sub> from <italic>Bothrops pirajai</italic> snake venom: Synthetic C-terminal peptide identifies its antiplatelet region</article-title><source>Arch. Toxicol.</source><year>2011</year><volume>85</volume><fpage>1219</fpage><lpage>1233</lpage><pub-id pub-id-type="doi">10.1007/s00204-011-0665-6</pub-id><?supplied-pmid 21331602?><pub-id pub-id-type="pmid">21331602</pub-id></element-citation></ref><ref id="B15-toxins-09-00342"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Laat</surname><given-names>M.</given-names></name><name><surname>Fern&#225;ndez</surname><given-names>J.</given-names></name><name><surname>Durban</surname><given-names>J.</given-names></name><name><surname>Villalobos</surname><given-names>E.</given-names></name><name><surname>Camacho</surname><given-names>E.</given-names></name><name><surname>Calvete</surname><given-names>J.</given-names></name><name><surname>Lomonte</surname><given-names>B.</given-names></name></person-group><article-title>Amino acid sequence and biological characterization of BlatPLA<sub>2</sub>, a non-toxic acidic phospholipase A<sub>2</sub> from the venom of the arboreal snake <italic>Bothriechis lateralis</italic> from Costa Rica</article-title><source>Toxicon</source><year>2013</year><volume>73</volume><fpage>71</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2013.07.008</pub-id><?supplied-pmid 23872034?><pub-id pub-id-type="pmid">23872034</pub-id></element-citation></ref><ref id="B16-toxins-09-00342"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>R.</given-names></name><name><surname>Izidoro</surname><given-names>L.</given-names></name><name><surname>Teixeira</surname><given-names>S.</given-names></name><name><surname>Silveira</surname><given-names>L.</given-names></name><name><surname>Hamaguchi</surname><given-names>A.</given-names></name><name><surname>Homsi-Brandeburgo</surname><given-names>M.</given-names></name><name><surname>Selistre-de-Ara&#250;jo</surname><given-names>H.</given-names></name><name><surname>Giglio</surname><given-names>J.</given-names></name><name><surname>Fuly</surname><given-names>A.</given-names></name><name><surname>Soares</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Isolation and functional characterization of a new myotoxic acidic phospholipase A<sub>2</sub> from <italic>Bothrops pauloensis</italic> snake venom</article-title><source>Toxicon</source><year>2007</year><volume>50</volume><fpage>153</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2007.03.005</pub-id><?supplied-pmid 17451767?><pub-id pub-id-type="pmid">17451767</pub-id></element-citation></ref><ref id="B17-toxins-09-00342"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos-Filho</surname><given-names>N.</given-names></name><name><surname>Silveira</surname><given-names>L.</given-names></name><name><surname>Oliveira</surname><given-names>C.</given-names></name><name><surname>Bernardes</surname><given-names>C.</given-names></name><name><surname>Menaldo</surname><given-names>D.</given-names></name><name><surname>Fuly</surname><given-names>A.</given-names></name><name><surname>Arantes</surname><given-names>E.</given-names></name><name><surname>Sampaio</surname><given-names>S.</given-names></name><name><surname>Mameded</surname><given-names>C.</given-names></name><name><surname>Beletti</surname><given-names>M.</given-names></name><etal/></person-group><article-title>A new acidic myotoxic, anti-platelet and prostaglandin I2 inductor phospholipase A<sub>2</sub> isolated from <italic>Bothrops moojeni</italic> snake venom</article-title><source>Toxicon</source><year>2008</year><volume>52</volume><fpage>908</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2008.08.020</pub-id><?supplied-pmid 18929590?><pub-id pub-id-type="pmid">18929590</pub-id></element-citation></ref><ref id="B18-toxins-09-00342"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serrano</surname><given-names>S.</given-names></name><name><surname>Reichl</surname><given-names>A.</given-names></name><name><surname>Mentele</surname><given-names>R.</given-names></name><name><surname>Auerswald</surname><given-names>E.</given-names></name><name><surname>Santoro</surname><given-names>M.</given-names></name><name><surname>Sampaio</surname><given-names>C.</given-names></name><name><surname>Camargo</surname><given-names>A.</given-names></name><name><surname>Assakura</surname><given-names>M.</given-names></name></person-group><article-title>A novel Phospholipase A<sub>2</sub>, BJ-PLA<sub>2</sub>, from the venom of the snake <italic>Bothrops jararaca</italic>: purification, primary structure analysis, and its characterization as a platelet-aggregation-inhibiting factor</article-title><source>Arch. Biochem. Biophys.</source><year>1999</year><volume>367</volume><fpage>26</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1006/abbi.1999.1230</pub-id><?supplied-pmid 10375395?><pub-id pub-id-type="pmid">10375395</pub-id></element-citation></ref><ref id="B19-toxins-09-00342"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silveira</surname><given-names>L.</given-names></name><name><surname>Marchi-Salvador</surname><given-names>D.</given-names></name><name><surname>Santos-Filho</surname><given-names>N.</given-names></name><name><surname>Silva</surname><given-names>F.</given-names><suffix>Jr.</suffix></name><name><surname>Marcussie</surname><given-names>S.</given-names></name><name><surname>Fuly</surname><given-names>A.</given-names></name><name><surname>Nomizo</surname><given-names>A.</given-names></name><name><surname>Da Silva</surname><given-names>S.</given-names></name><name><surname>St&#225;beli</surname><given-names>R.</given-names></name><name><surname>Arantes</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Isolation and expression of a hypotensive and anti-platelet acidic phospholipase A<sub>2</sub> from <italic>Bothrops moojeni</italic> snake venom</article-title><source>J. Pharm. Biomed. Anal.</source><year>2013</year><volume>73</volume><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2012.04.008</pub-id><?supplied-pmid 22571953?><pub-id pub-id-type="pmid">22571953</pub-id></element-citation></ref><ref id="B20-toxins-09-00342"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunes</surname><given-names>D.</given-names></name><name><surname>Rodrigues</surname><given-names>R.</given-names></name><name><surname>Lucena</surname><given-names>M.</given-names></name><name><surname>Cologna</surname><given-names>C.</given-names></name><name><surname>Oliveira</surname><given-names>A.</given-names></name><name><surname>Hamaguchi</surname><given-names>A.</given-names></name><name><surname>Homsi-Brandeburgo</surname><given-names>M.</given-names></name><name><surname>Arantes</surname><given-names>E.</given-names></name><name><surname>Teixeira</surname><given-names>D.</given-names></name><name><surname>Ueira-Vieira</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Isolation and functional characterization of proinflammatory acidic phospholipase A<sub>2</sub> from <italic>Bothrops leucurus</italic> snake venom</article-title><source>Comp. Biochem. Physiol. C</source><year>2011</year><volume>154</volume><fpage>226</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1016/j.cbpc.2011.06.003</pub-id><?supplied-pmid 21699995?><pub-id pub-id-type="pmid">21699995</pub-id></element-citation></ref><ref id="B21-toxins-09-00342"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mora-Obando</surname><given-names>D.</given-names></name><name><surname>Fern&#225;ndez</surname><given-names>J.</given-names></name><name><surname>Montecucco</surname><given-names>C.</given-names></name><name><surname>Guti&#233;rrez</surname><given-names>J.M.</given-names></name><name><surname>Lomonte</surname><given-names>B.</given-names></name></person-group><article-title>Synergism between basic Asp49 and Lys49 phospholipase A<sub>2</sub> myotoxins of viperid snake venom in vitro and in vivo</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e109846</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0109846</pub-id><?supplied-pmid 25290688?><pub-id pub-id-type="pmid">25290688</pub-id></element-citation></ref><ref id="B22-toxins-09-00342"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kini</surname><given-names>R.M.</given-names></name></person-group><article-title>Structure&#8211;function relationships and mechanism of anticoagulant phospholipase A<sub>2</sub> enzymes from snake venoms</article-title><source>Toxicon</source><year>2005</year><volume>45</volume><fpage>1147</fpage><lpage>1161</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2005.02.018</pub-id><?supplied-pmid 15922780?><pub-id pub-id-type="pmid">15922780</pub-id></element-citation></ref><ref id="B23-toxins-09-00342"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laemmli</surname><given-names>U.K.</given-names></name></person-group><article-title>Cleavage of structural proteins during the assembly of the head of bacteriophage T4</article-title><source>Nature</source><year>1970</year><volume>227</volume><fpage>680</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1038/227680a0</pub-id><?supplied-pmid 5432063?><pub-id pub-id-type="pmid">5432063</pub-id></element-citation></ref><ref id="B24-toxins-09-00342"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edman</surname><given-names>P.</given-names></name><name><surname>Begg</surname><given-names>G.</given-names></name></person-group><article-title>A protein sequentor</article-title><source>Eur. J. Biochem.</source><year>1967</year><volume>1</volume><fpage>80</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1111/j.1432-1033.1967.tb00047.x</pub-id><?supplied-pmid 6059350?><pub-id pub-id-type="pmid">6059350</pub-id></element-citation></ref><ref id="B25-toxins-09-00342"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altschul</surname><given-names>S.F.</given-names></name><name><surname>Madden</surname><given-names>T.L.</given-names></name><name><surname>Sch&#228;ffer</surname><given-names>A.A.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Miller</surname><given-names>W.</given-names></name><name><surname>Lipman</surname><given-names>D.J</given-names></name></person-group><article-title>Gapped BLAST and PSI-BLAST: A new generation of protein database search programs</article-title><source>Nucleic Acids Res.</source><year>1997</year><volume>25</volume><fpage>3389</fpage><lpage>3402</lpage><pub-id pub-id-type="pmid">9254694</pub-id></element-citation></ref><ref id="B26-toxins-09-00342"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corpet</surname><given-names>F.</given-names></name></person-group><article-title>Multiple sequence alignment with hierarchical clustering</article-title><source>Nucleic Acids Res.</source><year>1988</year><volume>16</volume><fpage>10881</fpage><lpage>10890</lpage><pub-id pub-id-type="doi">10.1093/nar/16.22.10881</pub-id><?supplied-pmid 2849754?><pub-id pub-id-type="pmid">2849754</pub-id></element-citation></ref><ref id="B27-toxins-09-00342"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamura</surname><given-names>K.</given-names></name><name><surname>Stecher</surname><given-names>G.</given-names></name><name><surname>Peterson</surname><given-names>D.</given-names></name><name><surname>Filipski</surname><given-names>A.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name></person-group><article-title>MEGA6: Molecular Evolutionary Genetics Analysis, version 6.0</article-title><source>Mol. Biol. Evol.</source><year>2013</year><volume>30</volume><fpage>2725</fpage><lpage>2729</lpage><pub-id pub-id-type="doi">10.1093/molbev/mst197</pub-id><?supplied-pmid 24132122?><pub-id pub-id-type="pmid">24132122</pub-id></element-citation></ref><ref id="B28-toxins-09-00342"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearson</surname><given-names>W.R.</given-names></name><name><surname>Lipman</surname><given-names>D.J.</given-names></name></person-group><article-title>Improved tools for biological sequence comparison</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1988</year><volume>85</volume><fpage>2444</fpage><lpage>2448</lpage><pub-id pub-id-type="doi">10.1073/pnas.85.8.2444</pub-id><?supplied-pmid 3162770?><pub-id pub-id-type="pmid">3162770</pub-id></element-citation></ref><ref id="B29-toxins-09-00342"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasteiger</surname><given-names>E.</given-names></name><name><surname>Gattiker</surname><given-names>A.</given-names></name><name><surname>Hoogland</surname><given-names>C.</given-names></name><name><surname>Ivanyi</surname><given-names>I.</given-names></name><name><surname>Appel</surname><given-names>R.</given-names></name><name><surname>Bairoch</surname><given-names>A.</given-names></name></person-group><article-title>ExPASy: The proteomics server for in-depth protein knowledge and analysis</article-title><source>Nucleic Acids Res.</source><year>2003</year><volume>31</volume><fpage>3784</fpage><lpage>3788</lpage><pub-id pub-id-type="doi">10.1093/nar/gkg563</pub-id><?supplied-pmid 12824418?><pub-id pub-id-type="pmid">12824418</pub-id></element-citation></ref><ref id="B30-toxins-09-00342"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sali</surname><given-names>A.</given-names></name><name><surname>Blundell</surname><given-names>T.L.</given-names></name></person-group><article-title>Comparative protein modelling by satisfaction of spatial restraints</article-title><source>J. Mol. Biol.</source><year>1993</year><volume>234</volume><fpage>779</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1006/jmbi.1993.1626</pub-id><?supplied-pmid 8254673?><pub-id pub-id-type="pmid">8254673</pub-id></element-citation></ref><ref id="B31-toxins-09-00342"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webb</surname><given-names>B.</given-names></name><name><surname>Sali</surname><given-names>A.</given-names></name></person-group><article-title>Comparative protein structure modeling using Modeller</article-title><source>Protein Struct. Predict.</source><year>2014</year><volume>47</volume><fpage>1</fpage><lpage>15</lpage></element-citation></ref><ref id="B32-toxins-09-00342"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laskowski</surname><given-names>R.</given-names></name><name><surname>MacArthur</surname><given-names>M.</given-names></name><name><surname>Moss</surname><given-names>D.</given-names></name><name><surname>Hornton</surname><given-names>D.</given-names></name></person-group><article-title>PROCHECK: A program to check the stereochemical quality of protein structures</article-title><source>J. Appl. Crystallogr.</source><year>1993</year><volume>26</volume><fpage>283</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1107/S0021889892009944</pub-id></element-citation></ref><ref id="B33-toxins-09-00342"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sippl</surname><given-names>M.</given-names></name></person-group><article-title>Recognition of errors in three-dimensional structures of proteins</article-title><source>Proteins</source><year>1993</year><volume>17</volume><fpage>355</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1002/prot.340170404</pub-id><?supplied-pmid 8108378?><pub-id pub-id-type="pmid">8108378</pub-id></element-citation></ref><ref id="B34-toxins-09-00342"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiederstein</surname><given-names>M.</given-names></name><name><surname>Sippl</surname><given-names>M.</given-names></name></person-group><article-title>ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins</article-title><source>Nucleic Acids Res.</source><year>2007</year><volume>35</volume><fpage>W407</fpage><lpage>W410</lpage><pub-id pub-id-type="doi">10.1093/nar/gkm290</pub-id><?supplied-pmid 17517781?><pub-id pub-id-type="pmid">17517781</pub-id></element-citation></ref><ref id="B35-toxins-09-00342"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowie</surname><given-names>J.U.</given-names></name><name><surname>Luthy</surname><given-names>R.</given-names></name><name><surname>Eisenberg</surname><given-names>D.</given-names></name></person-group><article-title>A method to identify protein sequences that fold into a known three-dimensional structure</article-title><source>Science</source><year>1991</year><volume>253</volume><fpage>164</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1126/science.1853201</pub-id><?supplied-pmid 1853201?><pub-id pub-id-type="pmid">1853201</pub-id></element-citation></ref><ref id="B36-toxins-09-00342"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guti&#233;rrez</surname><given-names>J.M.</given-names></name><name><surname>Lomonte</surname><given-names>B.</given-names></name><name><surname>Chaves</surname><given-names>F.</given-names></name><name><surname>Moreno</surname><given-names>E.</given-names></name><name><surname>Cerdas</surname><given-names>L.</given-names></name></person-group><article-title>Pharmacological activities of a toxic phospholipase A<sub>2</sub> isolated from the venom of the snake <italic>Bothrops asper</italic></article-title><source>Comp. Biochem. Physiol. C</source><year>1986</year><volume>84</volume><fpage>159</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/0742-8413(86)90183-0</pub-id><pub-id pub-id-type="pmid">2873948</pub-id></element-citation></ref><ref id="B37-toxins-09-00342"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>W.</given-names></name><name><surname>K&#233;zdy</surname><given-names>F.J.</given-names></name></person-group><article-title>Chromogenic phospholipase A<sub>2</sub> substrates and assays</article-title><source>Methods Enzymol.</source><year>1991</year><volume>197</volume><fpage>75</fpage><lpage>79</lpage><?supplied-pmid 2051947?><pub-id pub-id-type="pmid">2051947</pub-id></element-citation></ref><ref id="B38-toxins-09-00342"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holzer</surname><given-names>M.</given-names></name><name><surname>Mackessy</surname><given-names>S.P.</given-names></name></person-group><article-title>An aqueous endpoint assay of snake venom phospholipase A<sub>2</sub></article-title><source>Toxicon</source><year>1996</year><volume>34</volume><fpage>1149</fpage><lpage>1155</lpage><pub-id pub-id-type="doi">10.1016/0041-0101(96)00057-8</pub-id><pub-id pub-id-type="pmid">8931255</pub-id></element-citation></ref><ref id="B39-toxins-09-00342"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lomonte</surname><given-names>B.</given-names></name><name><surname>Tarkowski</surname><given-names>A.</given-names></name><name><surname>Hanson</surname><given-names>L.A.</given-names></name></person-group><article-title>Host response to <italic>Bothrops asper</italic> snake venom: analysis of edema formation, inflammatory cells, and cytokine release in a mouse model</article-title><source>Inflammation</source><year>1993</year><volume>17</volume><fpage>93</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1007/BF00916097</pub-id><?supplied-pmid 8491517?><pub-id pub-id-type="pmid">8491517</pub-id></element-citation></ref><ref id="B40-toxins-09-00342"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guti&#233;rrez</surname><given-names>J.M.</given-names></name><name><surname>Lomonte</surname><given-names>B.</given-names></name><name><surname>Cerdas</surname><given-names>L.</given-names></name></person-group><article-title>Isolation and partial characterization of a myotoxin from the venom of the snake <italic>Bothrops nummifer</italic></article-title><source>Toxicon</source><year>1986</year><volume>24</volume><fpage>885</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1016/0041-0101(86)90089-9</pub-id><pub-id pub-id-type="pmid">3810663</pub-id></element-citation></ref><ref id="B41-toxins-09-00342"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera</surname><given-names>C.</given-names></name><name><surname>Rucavado</surname><given-names>A.</given-names></name><name><surname>Warrell</surname><given-names>D.A.</given-names></name><name><surname>Guti&#233;rrez</surname><given-names>J.M.</given-names></name></person-group><article-title>Systemic effects induced by the venom of the snake <italic>Bothrops caribbaeus</italic> in a murine model</article-title><source>Toxicon</source><year>2013</year><volume>63</volume><fpage>19</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2012.10.023</pub-id><?supplied-pmid 23159397?><pub-id pub-id-type="pmid">23159397</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="toxins-09-00342-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Isolation of BaCol PLA<sub>2</sub> (acidic Asp49 phospholipases A<sub>2</sub>). (<bold>A</bold>) Elution profile of <italic>B. asper</italic> venom by RP-HPLC (reverse-phase high performance liquid chromatography) on a Resteck C18 semi-preparative column. The fraction indicated by the arrow showed high PLA<sub>2</sub> activity; (<bold>B</bold>) The PLA<sub>2</sub> fraction was analyzed by RP-HPLC and purity was assessed by SDS-PAGE on a 12% polyacrylamide gel in reducing conditions. MM&#8211;molecular mass markers (in kDa); (<bold>C</bold>) Isoelectric focusing in a 10% polyacrylamide gel (pI range: 3&#8211;10). MM: molecular mass markers (in kDa).</p></caption><graphic xlink:href="toxins-09-00342-g001"/></fig><fig id="toxins-09-00342-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Mass spectrometric analysis of BaCol PLA<sub>2</sub>. (<bold>A</bold>) Spectrum obtained in multi-charge mode, as described in Materials and Methods; the inset (<bold>B</bold>) shows the deconvolution of the multi-charged ion series indicated in (<bold>A</bold>).</p></caption><graphic xlink:href="toxins-09-00342-g002"/></fig><fig id="toxins-09-00342-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>cDNA and translated amino acid sequence of BaCol PLA<sub>2</sub>. The <italic>N</italic>-terminal sequence (first 25 amino acids) determined by direct Edman degradation is underlined.</p></caption><graphic xlink:href="toxins-09-00342-g003"/></fig><fig id="toxins-09-00342-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Multiple sequence alignment of BaCol PLA<sub>2</sub> with other PLA<sub>2</sub> isolated from <italic>Bothrops</italic> snake venoms. Protein access codes are indicated in the first column. The number of amino acids, percentage identity compared to BaCol PLA<sub>2</sub> and the species of origin are also indicated. Cysteine residues are highlighted in dark gray and amino acid sequence variants in light gray. The loop for calcium residues are highlighted in red. The residues of the active site are indicated with blue boxes. The residues of the putative site for anti-clotting activity are underlined with orange.</p></caption><graphic xlink:href="toxins-09-00342-g004"/></fig><fig id="toxins-09-00342-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Three-dimensional model of BaCol PLA<sub>2</sub>. The active site residues (Asp and His) of the enzyme are shown in sticks and Ca<sup>2+</sup> is shown as a light green sphere.</p></caption><graphic xlink:href="toxins-09-00342-g005"/></fig><fig id="toxins-09-00342-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>BaCol PLA<sub>2</sub> activity and edema formation. (<bold>A</bold>) Indirect hemolytic activity of BaCol PLA<sub>2</sub> (15 &#181;g/&#181;L) and venom (15 &#181;g/&#181;L) assayed using human erythrocytes and egg yolk as substrate. Activity was expressed as the diameter of the hemolytic halo after incubation for 20 h at 37 &#176;C (<bold>B</bold>) Hydrolysis of the synthetic substrate 4-nitro-3-octanoyloxy-benzoic acid by BaCol PLA<sub>2</sub> (1 &#181;g/&#181;L) and venom (1 &#181;g/&#181;L), measured as the increase in absorbance after incubation for 1 h at 37 &#176;C; (<bold>C</bold>) Mouse hind paw edema induced by BaCol PLA<sub>2</sub>. PBS (50 &#181;L) (white circles) or BaCol PLA<sub>2</sub> (5 &#181;g&#8212;gray circles or 20 &#181;g&#8212;black circles) in 50 &#181;L of PBS was injected into the hind footpad of male Swiss-Webster mice and edema formation was monitored as the increase in footpad thickness for up to 3 h, using calipers. The columns and points are the mean &#177; SD <italic>n</italic> = 3 (panels <bold>A</bold> and <bold>B</bold>) and 4 in (panel <bold>C</bold>); * <italic>p</italic> &lt; 0.05 compared to PBS or the corresponding control; *** <italic>p</italic> &lt; 0.001 compares to PBS or the corresponding control.</p></caption><graphic xlink:href="toxins-09-00342-g006"/></fig><fig id="toxins-09-00342-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Myonecrosis caused by BaCol PLA<sub>2</sub> in mouse gastrocnemius muscle. (<bold>A</bold>) Plasma CK activity 3 h after injection of BaCol PLA<sub>2</sub> (50 &#181;g/100 &#181;L, i.m.) compared to mice injected i.m. with 0.9% NaCl (control); (<bold>B</bold>) Percentage of necrosis determined as described in the Methods; (<bold>C</bold>,<bold>D</bold>) Histology of gastrocnemius muscle injected with 0.9% NaCl (control) and BaCol PLA<sub>2</sub>, respectively. Hematoxylin and Eosin staining. The columns in (<bold>A</bold>,<bold>B</bold>) are the mean &#177; SD (<italic>n</italic> = 4); * <italic>p</italic> &lt; 0.05 compared to control mice. The white bar represents 10 microns.</p></caption><graphic xlink:href="toxins-09-00342-g007"/></fig><fig id="toxins-09-00342-f008" orientation="portrait" position="float"><label>Figure 8</label><caption><p>Cytotoxicity of BaCol PLA<sub>2</sub> in U937 lymphocytes. (<bold>A</bold>) Normal cells not incubated with BaCol PLA<sub>2</sub> (viability: 85%); (<bold>B</bold>) Cells incubated with BaCol PLA<sub>2</sub> (1.6 &#181;g/&#181;L) (membrane damage: 82%); (<bold>C</bold>) Cell membrane damage (%) induced by BaCol PLA<sub>2</sub> compared to control (non-treated) cells. The columns are the mean &#177; SD (<italic>n</italic> = 3); (<bold>D</bold>) Cell membrane damage induced by BaCol PLA<sub>2</sub> (0.16 &#181;g/&#181;L); (<bold>E</bold>) Negative control for annexin V conjugated with phycoerythrin; (<bold>F</bold>) Cells incubated with BaCol PLA<sub>2</sub> (0.16 &#181;g/&#181;L). There was no phosphatidylserine exposure indicative of early apoptosis. * <italic>p</italic> &lt; 0.05 compared to control cells.</p></caption><graphic xlink:href="toxins-09-00342-g008"/></fig><table-wrap id="toxins-09-00342-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">toxins-09-00342-t001_Table 1</object-id><label>Table 1</label><caption><p>Comparative characteristics between BaCol PLA<sub>2</sub> and other acidic PLA<sub>2</sub>s.</p></caption></table-wrap></floats-group></article>